Calendar Crinetics Pharmaceuticals, Inc.

Equities

CRNX

US22663K1079

Market Closed - Nasdaq 04:00:00 2024-04-12 pm EDT 5-day change 1st Jan Change
44.59 USD -7.16% Intraday chart for Crinetics Pharmaceuticals, Inc. -6.19% +25.32%

Chart calendar Crinetics Pharmaceuticals, Inc.

ab5f9156d2e1.C-r8LNAdKo4t7p2_NvEvBFu-rozW8QSJ5OYnKC8TJgI.R9OjfIdNcOgVu_OJV5hCZWLZ672enl7Ri9FzRnVCb2lDp8pzgixywm7b0A~31be217b959214e183dcbf351dec6ad0

Upcoming events on Crinetics Pharmaceuticals, Inc.

2024-05-09 Q1 2024 Earnings Release (Projected)
2024-08-08 Q2 2024 Earnings Release (Projected)
2024-11-11 Q3 2024 Earnings Release (Projected)
2025-03-17 Q4 2024 Earnings Release (Projected)

Past events on Crinetics Pharmaceuticals, Inc.

2024-03-19 08:30 am PATHFNDR 2 Phase 3 Study Results Call
2024-03-12 04:30 pm Paltusotine Phase 2 Study Results Call
2024-02-28 04:30 pm Q4 2023 Earnings Call
2024-02-28 04:05 pm Q4 2023 Earnings Release
2024-01-09 06:45 pm JPMorgan Healthcare Conference
2023-12-18 05:00 pm Business Update Call
2023-11-30 08:00 am Piper Sandler Healthcare Conference
2023-11-28 03:50 pm Evercore ISI HealthCONx Conference
2023-11-07 04:05 pm Q3 2023 Earnings Release
2023-09-26 01:00 pm Cantor Global Healthcare Conference
2023-09-11 08:00 am Paltusotine PATHFNDR-1 Phase 3 Study Results Call
2023-08-08 12:00 pm Investor Meeting - Key Opinion Leader
2023-08-08 07:00 am Q2 2023 Earnings Release
2023-06-18 09:00 am Endocrine Society Meeting - Oral Session OR30
2023-06-17 02:00 pm Endocrine Society Meeting - Poster SAT-182
2023-06-17 02:00 pm Endocrine Society Meeting - Poster SAT-628
2023-06-16 01:00 pm Endocrine Society Meeting - Poster FRI-546
2023-06-15 Annual General Meeting
2023-06-15 11:00 am Endocrine Society Meeting - Oral Session OR01
2023-06-13 12:00 am H.C. Wainwright Emerging Ideas in Biopharma

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1,19
1,03
15.68%
0,07
0,09
-19.68%
1,08
0,00
-
4,74
4,32
9.73%
4,01
4,21
-4.73%

1,50

EBITDA
Million USD
Released
Forecast
Spread
-52,9
-53,7
1.42%
-74,0
-68,7
-7.67%
-107
-106
-0.38%
-167
-167
0.04%
-222
-220
-0.58%

-263

EBIT
Million USD
Released
Forecast
Spread
-53,8
-55,4
2.76%
-75,0
-73,4
-2.18%
-108
-106
-1.96%
-168
-166
-1.3%
-223
-216
-2.92%

-260

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-50,4
-52,3
3.52%
-73,8
-72,4
-1.88%
-108
-105
-2.07%
-164
-164
-0.22%
-209
-207
-1.34%

-244

Net income
Million USD
Released
Forecast
Spread
-50,4
-52,2
3.41%
-73,8
-71,7
-2.96%
-108
-105
-2.74%
-164
-163
-0.59%
-215
-209
-2.77%

-245

EPS
USD
Released
Forecast
Spread
-2,09
-2,16
3.36%
-2,42
-2,35
-2.93%
-2,80
-2,70
-3.64%
-3,15
-3,22
2.3%
-3,69
-3,58
-3.06%

-3,30

Announcement Date09/03/2030/03/2130/03/2228/02/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
1,08
0,00
-
3,13
5,20
-39.79%
0,44
0,72
-39.03%
0,46
0,20
129%
0,71
0,30
136.33%
2,68
0,24
997.32%
0,99
1,28
-22.8%
0,35
0,14
145.15%
0,00
0,18
-

0,10


0,60


0,10


0,60


0,03

EBITDA
Million USD
Released
Forecast
Spread
-30,7
-30,0
-2.18%
-33,6
-21,0
-59.94%
-42,8
-37,0
-15.76%
-43,2
-44,0
1.8%
-47,3
-47,0
-0.59%
-47,7
-49,0
2.66%






-62,4
-60,0
-3.99%

-60,1


-62,7


-65,8


-69,4




EBIT
Million USD
Released
Forecast
Spread
-30,9
-29,4
-5.23%
-33,8
-28,0
-20.79%
-43,0
-35,6
-21%
-43,5
-44,6
2.47%
-47,6
-45,5
-4.5%
-48,0
-48,4
0.85%
-53,0
-47,5
-11.54%
-59,0
-51,0
-15.65%
-62,7
-55,1
-13.77%

-63,3


-65,1


-67,3


-69,0


-68,1

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,8
-29,2
-5.49%
-34,6
-27,8
-24.45%
-42,4
-34,5
-22.71%
-41,9
-43,7
4%
-45,0
-45,3
0.63%
-46,0
-47,5
3.11%
-51,0
-46,4
-9.88%
-57,5
-48,0
-19.59%
-55,9
-54,0
-3.46%

-59,6


-61,4


-63,6


-65,3


-65,0

Net income
Million USD
Released
Forecast
Spread
-30,8
-28,2
-9.31%
-34,6
-28,1
-23.26%
-42,4
-34,0
-24.45%
-41,9
-42,6
1.54%
-45,0
-44,1
-1.95%
-46,0
-47,0
2.13%
-51,0
-47,5
-7.22%
-57,5
-49,3
-16.44%
-60,1
-54,8
-9.66%

-60,2


-61,4


-63,6


-65,3


-65,0

EPS
USD
Released
Forecast
Spread
-0,68
-0,60
-12.96%
-0,73
-0,56
-29.55%
-0,81
-0,66
-23.51%
-0,78
-0,81
4%
-0,84
-0,83
-1.82%
-0,85
-0,84
-1.46%
-0,94
-0,86
-9.67%
-1,01
-0,86
-17.44%
-0,90
-0,88
-2.85%

-0,82


-0,80


-0,84


-0,85


-0,91

Announcement Date30/03/2212/05/2212/08/2214/11/2228/02/2304/05/2308/08/2307/11/2328/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CRNX Stock
  4. Calendar Crinetics Pharmaceuticals, Inc.